Related references
Note: Only part of the references are listed.Targeting cardiovascular inflammation: next steps in clinical translation
Patrick R. Lawler et al.
EUROPEAN HEART JOURNAL (2021)
Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes
Robert Wagner et al.
NATURE MEDICINE (2021)
Identification of two novel subgroups in patients with diabetes mellitus and their association with clinical outcomes: A two-step cluster analysis
Xiao-fen Xiong et al.
JOURNAL OF DIABETES INVESTIGATION (2021)
Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes
Christian Herder et al.
DIABETES (2021)
Type 2 Diabetes Subgroups, Risk for Complications, and Differential Effects Due to an Intensive Lifestyle Intervention
Michael P. Bancks et al.
DIABETES CARE (2021)
Meta-analyses of Results From Randomized Outcome Trials Comparing Cardiovascular Effects of SGLT2is and GLP-1RAs in Asian Versus White Patients With and Without Type 2 Diabetes
Matthew M. Y. Lee et al.
DIABETES CARE (2021)
Association of Diabetes Subgroups With Race/Ethnicity, Risk Factor Burden and Complications: The MASALA and MESA Studies
Michael P. Bancks et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Glomerular filtration rate decline in T2DM following diagnosis. The Verona newly diagnosed diabetes study-12
Giacomo Zoppini et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2021)
Novel therapies with precision mechanisms for type 2 diabetes mellitus
Leigh Perreault et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study
Roderick C. Slieker et al.
DIABETES (2021)
Leukocyte Counts and T-Cell Frequencies Differ Between Novel Subgroups of Diabetes and Are Associated With Metabolic Parameters and Biomarkers of Inflammation
Jacqueline M. Ratter-Rieck et al.
DIABETES (2021)
Replication and cross-validation of type 2 diabetes subtypes based on clinical variables: an IMI-RHAPSODY study
Roderick C. Slieker et al.
DIABETOLOGIA (2021)
Comparison between data-driven clusters and models based on clinical features to predict outcomes in type 2 diabetes: nationwide observational study
Moa Lugner et al.
DIABETOLOGIA (2021)
Toward an Improved Classification of Type 2 Diabetes: Lessons From Research into the Heterogeneity of a Complex Disease
Maria J. Redondo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Novel Reclassification of Adult Diabetes Is Useful to Distinguish Stages of β-Cell Function Linked to the Risk of Vascular Complications: The DOLCE Study From Northern Ukraine
Olena Fedotkina et al.
FRONTIERS IN GENETICS (2021)
Clinical Characteristics and Risk of Diabetic Complications in Data-Driven Clusters Among Type 2 Diabetes
Lin Xing et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Clusters of people with type 2 diabetes in the general population: unsupervised machine learning approach using national surveys in Latin America and the Caribbean
Rodrigo M. Carrillo-Larco et al.
BMJ OPEN DIABETES RESEARCH & CARE (2021)
Adult-onset diabetes in Middle Eastern immigrants to Sweden: Novel subgroups and diabetic complications-The All New Diabetes in Scania cohort diabetic complications and ethnicity
Louise Bennet et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2021)
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia et al.
DIABETES CARE (2020)
Genetic Variation in Type 1 Diabetes Reconfigures the 3D Chromatin Organization of T Cells and Alters Gene Expression
Maria Fasolino et al.
IMMUNITY (2020)
Molecular Choreography of Acute Exercise
Kevin Contrepois et al.
CELL (2020)
Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN-6 cardiovascular outcomes trials
Anna R. Kahkoska et al.
DIABETES OBESITY & METABOLISM (2020)
Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes
Oana P. Zaharia et al.
DIABETES CARE (2020)
Precision medicine in diabetes:a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Wendy K. Chung et al.
DIABETOLOGIA (2020)
Factors Associated with Risk of Diabetic Complications in Novel Cluster-Based Diabetes Subgroups: A Japanese Retrospective Cohort Study
Hayato Tanabe et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Clinical characterization of data-driven diabetes subgroups in Mexicans using a reproducible machine learning approach
Omar Yaxmehen Bello-Chavolla et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Unraveling the molecular heterogeneity in type 2 diabetes: a potential subtype discovery followed by metabolic modeling
Maryam Khoshnejat et al.
BMC MEDICAL GENOMICS (2020)
Human postprandial responses to food and potential for precision nutrition
Sarah E. Berry et al.
NATURE MEDICINE (2020)
Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment
John M. Dennis
DIABETES (2020)
Subtypes of Type 2 Diabetes Determined From Clinical Parameters
Emma Ahlqvist et al.
DIABETES (2020)
The clinical consequences of heterogeneity within and between different diabetes types
Maria J. Redondo et al.
DIABETOLOGIA (2020)
The circulating ANGPTL8 levels show differences among novel subgroups of adult patients with diabetes and are associated with mortality in the subsequent 5 years
Huajie Zou et al.
SCIENTIFIC REPORTS (2020)
Biomarkers of Inflammation and Glomerular Filtration Rate in Individuals with Recent-Onset Type 1 and Type 2 Diabetes
Haifa Maalmi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Chronic complications in patients with newly diagnosed type 2 diabetes: prevalence and related metabolic and clinical features: the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9
Enzo Bonora et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study
Ranjit Mohan Anjana et al.
BMJ OPEN DIABETES RESEARCH & CARE (2020)
Post-load glucose subgroups and associated metabolic traits in individuals with type 2 diabetes: An IMI-DIRECT study
Morgan Obura et al.
PLOS ONE (2020)
The Identification of Diabetes Mellitus Subtypes Applying Cluster Analysis Techniques: A Systematic Review
Antonio Sarria-Santamera et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)
Type 2 diabetes subgroups and potential medication strategies in relation to effects on insulin resistance and beta-cell function: A step toward personalised diabetes treatment?
Anna Veelen et al.
MOLECULAR METABOLISM (2020)
The Genetic Basis of Metabolic Disease
Ines Barroso et al.
CELL (2019)
Risk variants disrupting enhancers of TH1 and TREG cells in type 1 diabetes
Peng Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
A longitudinal big data approach for precision health
Sophia Miryam Schussler-Fiorenza Rose et al.
NATURE MEDICINE (2019)
Novel Subgroups of Type 2 Diabetes at Diagnosis in a Southern European Cohort
Riccardo C. Bonadonna et al.
DIABETES (2019)
Type 2 diabetes: a multifaceted disease
Ewan R. Pearson
DIABETOLOGIA (2019)
Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data
John M. Dennis et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study
Oana P. Zaharia et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Heterogeneity of diabetes: heralding the era of precision medicine
Stefano Del Prato
LANCET DIABETES & ENDOCRINOLOGY (2019)
Precision medicine in type 2 diabetes
R. B. Prasad et al.
JOURNAL OF INTERNAL MEDICINE (2019)
The integrative biology of type 2 diabetes
Michael Roden et al.
NATURE (2019)
Novel subgroups of patients with adult-onset diabetes in Chinese and US populations
Xiantong Zou et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Targeting innate immune mediators in type 1 and type 2 diabetes
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Metabolic Characteristics of Recently Diagnosed Adult-Onset Autoimmune Diabetes Mellitus
Oana P. Zaharia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Pathophysiological Characteristics Underlying Different Glucose Response Curves: A Latent Class Trajectory Analysis From the Prospective EGIR-RISC Study
Adam Hulman et al.
DIABETES CARE (2018)
Precision medicine in the management of type 2 diabetes
Anna L. Gloyn et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
Emma Ahlqvist et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
A Global Overview of Precision Medicine in Type 2 Diabetes
Hugo Fitipaldi et al.
DIABETES (2018)
Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis
Miriam S. Udler et al.
PLOS MEDICINE (2018)
Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps
Anubha Mahajan et al.
NATURE GENETICS (2018)
Painting a new picture of personalised medicine for diabetes
Mark I. McCarthy
DIABETOLOGIA (2017)
Cohort profile: the German Diabetes Study (GDS)
Julia Szendroedi et al.
CARDIOVASCULAR DIABETOLOGY (2016)
Prevalence of Cardiovascular Autonomic Neuropathy in a Cohort of Patients With Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS)
Giacomo Zoppini et al.
DIABETES CARE (2015)
Identification of type 2 diabetes subgroups through topological analysis of patient similarity
Li Li et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Gene-Lifestyle Interaction and Type 2 Diabetes: The EPIC InterAct Case-Cohort Study
Claudia Langenberg et al.
PLOS MEDICINE (2014)
Is type 2 diabetes a category error?
Edwin A. M. Gale
LANCET (2013)
Adiponectin Trajectories Before Type 2 Diabetes Diagnosis Whitehall II study
Adam G. Tabak et al.
DIABETES CARE (2012)
Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes Whitehall II Prospective Cohort Study
Maren Carstensen et al.
DIABETES (2010)
Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study
Adam G. Tabak et al.
LANCET (2009)
Share Paper
